Table 1.
Disease | LncRNA | Species | Function | Mechanism | Ref. |
---|---|---|---|---|---|
Aβ accumulation | 17A | H | Increases secretion of Aβ and Aβx-42/Aβx-40 peptide ratio | Promotes synthesis of an alternative splicing isoform of GABAB R2 which impairs GABA B2 intracellular signaling | [81] |
51A | H | Disease causing; produced as an antisense transcript of intron 1 of the SORL1 gene and leads to increased Aβ formation due to defected processing of APP | Reduces synthesis of SORL1 variant by inducing a splicing shift of SORL | [82,83] | |
BACE1-AS | H | Involved in production of Aβ1–42 in AD and its downregulation reduces the ability of BACE1 to cleave APP and delays the senile formation of plaques | BACE1-AS produces RNA duplexes by complementing with its protein partner HuD and mRNA BACE1 and therefore increases the stability and expression of BACE1 mRNA which helps to generates additional A1-42 | [84,85,28] | |
BC200 (in human)/BC1 (in mouse) | H/M | Promotes aggregation and provides protection in memory deficits and spatial learning | In human, gene expression is altered as BC200 binds with PABP1, a regulator of translation initiation, after being transported as ribonucleoprotein particles to the dendritic processes; in mouse, in association with FMRP, APP mRNA translation and aggregation of Ab in brain are induced by BC1 | [86], [87], [88],49] | |
NDM29 | H | NDM29 is upregulated in patients with neurodegenerative diseases | Increases Aβ secretion and the Aβx-42/Aβx-40 ratio, due to increase in the synthesis of APP, induced by NDM29-dependent cell maturation | [89], [90], [91] | |
LRP1-AS | H/M | Transcribed antisense to LRP1; negatively regulates the APP trafficking and Aβ processing and Aβ accumulation function of LRP1 | Decreases LRP1 expression at protein and RNA levels by reducing LRP1 promoter activity induced by a transcriptional complex consisting of transcription factor Srebp1, and its interacting partner Hmgb2. | [61] | |
SNHG1 | H/M | Attenuation of the Aβ mediated effect by selectively targeting KREMEN1 | Aβ treatment induces expression of SNHG1 while repression of it in Aβ treated cells reduces effects of Aβ on MMP and cell viability; SNHG1 mediated miR-137 sponge causes attenuation of the Aβ mediated effect by selectively targeting KREMEN1 | [54], [55], [56] | |
Genetic polymorphism | TCONS_00021856/ linc-SLITRK5-11 |
H | Polymorphism in lncRNA TCONS_00021856/linc-SLITRK5-11 gene | At rs7990916 (T > C) is differentially present in Alzheimer's patients | [78] |
Immune response | H19 | H | Neuro-inflammation induction | HDAC1-dependent M1 microglial polarization is induced | [65] |
Lethe | M | Inflammatory signaling regulation | NF-kB subunit RelA binding with DNA is inhibited by Lethe- RelA interaction and corresponding target gene activation is halted | [66] | |
lincRNA-Cox2 | M | Distinct classes of immune gene expressions are either induced or inhibited | Interactions of lincRNA-Cox2 with heterogeneous nuclear; ribonucleoprotein A/B and A2/B1 is required for target gene inhibition | [42] | |
NEAT1 | H/M | Induces innate immune response; helps in activation of antiviral cytokine genes like IL-8 | NEAT1 binds with NONO, SFPQ, PSF, Ezh2 and relocates SFPQ from IL8 promoter to the paraspeckles, that results in transcriptional activation of IL8 | [66,[70], [71], [72], [73] | |
MALAT1 | H | Regulation of glucose mediated up-regulation of IL-6 and TNF- alpha | By activation of SAA3 expression | [74] | |
Neurogenesis and synaptic function | MALAT1 | H/M | Synaptic density regulation | By modulating the recruitment of SRSF1,SFPQ at the transcription site | [75], [76], [77] |
antisense UchL1 | M | By the regulation of UchL1, AS-UchL1 is involved in neurodegenerative diseases and brain function | Antisense Uchl1 RNA helps in overlapping Uchl1 mRNA for activation polysomes in translation purposes | [44] | |
Dali | H/M | Neural differentiation regulation | DNA methylation of CpG island-associated promoters are regulated in trans by the interaction of DNMT1 DNA methyltransferase in human and mouse | [67] | |
Miat | M | Neurogenic commitment | Dysregulation of Miat results in defective splicing of Wnt7b and has pleiotropic effects on brain development | [45] | |
Pnky | M | Neurogenesis regulation of embryonic and postnatal neural stem cell populations | By interacting with PTBP1, the splicing regulator | [46] | |
PVT1 | M | Autophagic inhibition in diabetes (and diabetes associated AD) decreases PVT1 concentration | Hippocampal neurons are protected from impairment of synaptic plasticity and apoptosis by PVT1-induced autophagy, and helps in betterment of cognitive impairment in diabetes | [47] | |
RMST | H | Neural stem cell fate regulation | Needed for the binding of promoter regions of neurogenic TFs to Sox2 | [68] | |
Evf2 | M | In early dentate gyrus and postnatal hippocampus mouse mutants of Evf2 showed less GABAergic interneurons | In the Dlx5/6 intergenic region DLX and MECP2 transcription factors are recruited that controls expression of Dlx5, Dlx6 and Gad1 | [48] | |
GDNFOS | H | Disease causing; transcribed from the opposite strand of GDNF gene | GDNFOS negatively regulates the expression of GDNF; therefore in mature temporal gyrus of AD patients, the GDNF peptide is downregulated | [59,60] | |
Sox2OT | H/M/R | Induction and/or maintenance of a TF Sox2 expression | In the cerebral cortex of the developing mouse brain, Sox2OT promotes neurogenesis and neuronal differentiation by repressing Sox2; it is also differentially expressed in early and late disease stages the AD model mouse. | [92,62,63] | |
BDNF-AS | H/M | Antisense transcript to BDNF, interacts with its protein binding partner PABPC1 and negatively regulates BDNF level | Decrease in BDNF level further down regulates an immediate-early gene, involved in synaptogenesis and synaptic plasticity called ARC | [93,31] | |
Neurogenesis and synaptic function and neuronal apoptosis | NAT-RAD18 | R | Disease causing and is upregulated in AD; transcribed from the antisense of protein coding gene Rad18 | NAT-Rad18 downregulates the expression of DNA repair protein Rad18 and enhance susceptibility to neuronal apoptosis; involved in PCNA ubiquitination, DNA repair and nerve injury | [57] |
EBF3-AS | H/M | Transcribed from the opposite strand of EBF3 and is up-regulated in the hippocampus of APP/PS1 mice | EBF3-AS deficiency decreases EBF3 levels inhibits OA or Aβ induced apoptosis in human SH-SY5Y cell | [37] | |
rRNA transcription and methylation | LoNA | M | Regulates rRNA transcription and methylation | rRNA transcription is regulated by binding to nucleolin and decreases its activity, while methylation is regulated by interaction with fibrillarin | [42,94] |